Stock market announcement archive

LIFE-ME: Scientific breakthrough Lifecare’s partner Digital Diagnostics AG detects corona virus with rapid test

June 2, 2020
Scientific breakthrough: Lifecare’s partner Digital Diagnostics AG detects corona virus with rapid test, seeks FDA approval and plans to deliver units starting in July The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has successfully detected SARS-CoV-2 viruses using the revolutionary Cantisense™ technology at the Helmholtz Centre for […]
Read more

LIFE-ME: Share options for primary insiders – extended exercise period.

April 1, 2020
The Board of Directors in Lifecare AS has extended the exercise period for: - 527.839 share options for Chief Operation Officer, Rune Frisvold; - 263.920 share options for Chief Scientific Officer, Andreas Pfützner, until April 1st, 2021. The options were issued December 2016 and has a strike price of NOK 0,40. This information is subject […]
Read more

Lifecare A/S (LIFE-ME) presented data at International Conference on Advanced Technology and Treatments fo …(Note: This headline has been truncated)

February 26, 2020
At the 13th International Conference on Advanced Technology and Treatments for Diabetes (ATTD) in Madrid, a key event for global scientist, leading healthcare professionals and life science decision makers, Lifecare A/S (LIFE-ME) presented a poster on its advances in the development of the Sencell Continuous Glucose monitor. The poster with the title “Miniaturization of an […]
Read more

LIFE-ME: Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology.

February 10, 2020
Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. 10.02.2020, Oslo Lifecare AS, a Norwegian life-science company, announced that they have filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. The purpose of this clinical pilot study is to explore the performance of the Sencell sensor technology […]
Read more

LIFE-ME: Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development!

January 20, 2020
Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development! Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory […]
Read more

STATEMENT OF CLARIFICATION – Lifecare signs joint venture to develop and digitize technologies

January 17, 2020
STATEMENT OF CLARIFICATION Lifecare AS’ Board would like to clarify and substantiate the notice published on the stock exchange on 15 January 2020: Lifecare AS and IMS Capital Partners GmbH have established Digital Diagnostics AG to complete Lifecare AS’ sensor technology, Sencell. The agreement between the parties entails that IMS Capital Partners GmbH will finance […]
Read more

REDEGJØRELSE – Lifecare signs joint venture to develop and digitize technologies

January 17, 2020
REDEGJØRELSE Styret i Lifecare AS vil presisere og utdype børsmelding datert 15. januar 2020: Lifecare AS og IMS Capital Partners GmbH har stiftet Digital Diagnostics AG for å ferdigstille Lifecare AS sin sensorteknologi, Sencell. Partenes samarbeidsavtale innebærer at IMS Capital Partners GmbH finansierer ferdigstillingen av Sencell, slik at Lifecare AS ikke har behov for planlagt […]
Read more

LIFE-ME: Sterna Holding AS aksjesalg

January 16, 2020
Sterna Holding AS, et selskap 100 % eid av Christian Saure som er styreformann og primærinnsider i Lifecare AS, har i dag solgt 250.000 aksjer i Lifecare AS på kurs 3,7155. Sterna Holding AS eier etter dette salget 3.350.000 aksjer tilsvarende 4,14 % av selskapet.
Read more

LIFE-ME: Lifecare signs joint venture to develop and digitize technologies

January 15, 2020
Lifecare signs joint venture to develop and digitize technologies Lifecare today announces an exciting joint venture to further develop Lifecare’s technology and digitize medical diagnostics. The joint venture with IMS Capital Partners will establish Digital Diagnostics AG, a company co-owned by IMS Capital Partners, Lifecare AS and employees. The deal will take effect from today […]
Read more